98 related articles for article (PubMed ID: 8484975)
1. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
[TBL] [Abstract][Full Text] [Related]
2. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
[TBL] [Abstract][Full Text] [Related]
3. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
Queirolo P; Repetto L; Gardin G; Miglietta L; Guido T; Pronzato P; Rosso R
J Chemother; 1991 Jun; 3(3):194-7. PubMed ID: 1919659
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
Bezwoda WR; Hesdorffer CS
Cancer; 1986 Jan; 57(2):218-21. PubMed ID: 3753656
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
Pectasides D; Mylonakis A; Antoniou F; Kostopoulou M; Triantaphyllis D; Papadopoulou M; Varthalitis J; Dimitriadis M; Athanassiou A
Oncology; 1998; 55(2):139-44. PubMed ID: 9499188
[TBL] [Abstract][Full Text] [Related]
7. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
Bezwoda WR; Dansey R; Seymour L
Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone, methotrexate, and 5-fluorouracil (MMF) in hormone-refractory advanced breast cancer.
Nortier JW; Neijt JP; Bleeker PA; Meeuwissen OJ; van Kessel D; van der Vegt S; Splinter T; van Groenestijn A; Schornagel JH
Neth J Med; 1989 Dec; 35(5-6):225-31. PubMed ID: 2635282
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
[TBL] [Abstract][Full Text] [Related]
11. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
12. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
[TBL] [Abstract][Full Text] [Related]
13. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of TMM (thiotepa, mitoxantrone and methotrexate) chemotherapy for metastatic breast cancer.
Bhardwaj S; Holland JF
Ann Oncol; 1990 Nov; 1(6):443-4. PubMed ID: 2128030
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy with a combination of mitoxantrone, methotrexate, 5-fluorouracil for node-positive breast cancer: phase II pilot study.
Kanno M; Nakamura S; Uotani C; Taniya T; Mura T; Bando H; Kawahara F; Tsugawa K; Noguchi M
J Chemother; 1999 Oct; 11(5):396-401. PubMed ID: 10632387
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer.
Alonso V; Santader C; Florian J; Alonso M; Isla MD; Escudero P; Saenz A; Tres A
Tumori; 1996; 82(1):61-4. PubMed ID: 8623508
[TBL] [Abstract][Full Text] [Related]
17. High-dose carboplatin and mitoxantrone with autologous bone marrow support in the treatment of advanced breast cancer.
Broun ER; Sledge GW; Einhorn LH; Tricot GJ
Am J Clin Oncol; 1993 Feb; 16(1):9-13. PubMed ID: 8424413
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
20. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]